Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine with different dexamethasone doses for thoracic paravertebral block analgesia after thoracoscopic lung resection
ChiCTR2600131262Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine and dexamethasone in postoperative pain (4 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Time to first rescue analgesia. Started Mar 2025; status: completed.
02
Drugs
ropivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600131262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131262.